Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283296 · ClinicalTrials.gov registry record · Phase 2
Development of a Collapsible Folding Manual Wheelchair
A Phase 2 study of Wheelchair Users, sponsored by VA Pittsburgh Healthcare System.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT00283296: Completed Phase 2 study of Wheelchair Users, sponsored by VA Pittsburgh Healthcare System.
NCT00283296 is a Phase 2 study of Wheelchair Users that has completed, run by VA Pittsburgh Healthcare System. The registered enrollment target is 14 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00283296, a Phase 2 study of Wheelchair Users, has completed, sponsored by VA Pittsburgh Healthcare System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate the Endeavor, a compact, forward-folding, ultralight manual wheelchair that incorporates small "swing-down" wheels for navigation in confined areas. This enables access to narrow environments such as those encountered in offices, restrooms, and transportation settings. When using the small access wheels, the wheelchair also fits down the aisle of airplanes and collapses to be stowed in the overhead compartment. It is anticipated that the Endeavor will maximize mobility; increase access to confined areas; and ease the demands of travel for people with disabilities.
Primary Outcome
Participants completed an Activities of Daily Living Course in their own personal w/c and the Endeavor. Then participants were asked to rate their level of difficulty to complete based on a 5 point likert scale: very difficult, difficult, moderate, easy, very easy. Number of participants reported the Endeavor w/c to be the same as their current w/c or better with regards to transporting in a vehicle.
Conditions Studied
Interventions
- DEVICE Endeavor
Study Locations (1)
Pennsylvania
- Human Engineering Research Laboratories - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2004-01 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
What the finished NCT00283296 record still lists
NCT00283296 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Wheelchair Users appearing as the primary indexed condition, and to 1 intervention - of which Endeavor is the first listed.
NCT00283296 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00283296 about?
NCT00283296 is a clinical study titled "Development of a Collapsible Folding Manual Wheelchair". The purpose of this research study is to evaluate the Endeavor, a compact, forward-folding, ultralight manual wheelchair that incorporates small "swing-down" wheels for navigation in confined areas. This enables access to narrow environments such as those encountered in offices, restrooms, and trans...
What is the current status of trial NCT00283296?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2004-01. Estimated completion is 2011-04.
What conditions does trial NCT00283296 study?
This clinical trial studies the following conditions: Wheelchair Users.
What interventions are being tested in trial NCT00283296?
The interventions under investigation include: Endeavor (DEVICE).
Who is sponsoring clinical trial NCT00283296?
This trial is sponsored by VA Pittsburgh Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00283296 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00283296's enrollment target sits among peer trials
14 1941st of 2000 higher than 54 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia